Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval crawled time : 07:00 save search
Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation
Published: 2024-02-29 (Crawled : 07:00) - prnewswire.com
INVVY | $21.8455 19.02% 8.1K
|
n/a
| Email alert
Add to watchlist
approval direct
Thermo Fisher Scientific Receives GMP approval from the Italian Medicines Agency (AIFA) for its Manufacturing facility of RNA-Based Products in Monza, Italy
Published: 2024-01-19 (Crawled : 07:00) - biospace.com/
TMO | News | $541.52 -1.05% 0.0% 5.4K
|
Health Technology
|
| O: 1.46%
H: 0.0%
C: 0.0%
approval
Everest Medicines Announces Approval of XERAVA® in Taiwan for the Treatment of Complicated Intra-Abdominal Infections in Adult Patients
Published: 2023-09-28 (Crawled : 07:00) - biospace.com/
INVA | $14.69 1.45% 1.43% 0
|
Health Technology
|
| O: -0.08%
H: 0.99%
C: 0.53%
xerava approval treatment infections
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Moderately to Severely Active Crohn's Disease
Published: 2023-04-17 (Crawled : 07:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.2%
H: 0.17%
C: -0.46%
rinvoq disease abbvie active approval treatment
Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry’s Medical Device Regulatory Approval in Indonesia
Published: 2023-03-08 (Crawled : 07:00) - predictmedix.com
PMEDF | $0.0285 4.4% -5.13% 0
|
Health Technology
|
| O: 1.3%
H: 0.0%
C: 0.0%
device medical approval study
Press Release: Dupixent® (dupilumab) recommended for expanded EU approval by the CHMP to treat children as young as six months old with severe atopic dermatitis
Published: 2023-01-27 (Crawled : 07:00) - globenewswire.com
SNY | News | $45.39 47K
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
REGN | $893.99 -0.8% -0.84% 0
|
Health Technology
|
| O: 0.45%
H: 0.36%
C: -0.37%
dupixent chmp children six dermatitis approval
Clinical Trial Approval For The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines Jiangsu Recbio Technology Co., Ltd. is pleased to announce that, the Group has recently...
Published: 2022-12-19 (Crawled : 07:00) - biospace.com/
MDGL | $222.26 -2.66% -2.8% 86
|
Health Technology
|
| O: 219.37%
H: 0.0%
C: 0.0%
rec610 vaccine technology trial approval group
Sienna Receives Government Approval for up to 4 Additional Holes on the Blue Clay Lithium Project in Clayton Valley, Nevada
Published: 2022-10-21 (Crawled : 07:00) - siennaresources.com
SNNAF | $0.0256 8.48% 0
|
Non-Energy Minerals
|
| O: 27.41%
H: 2.52%
C: -8.47%
lithium approval blue
Approval of Jyske Bank’s acquisition of Svenska Handelsbanken’s activities in Denmark
Published: 2022-10-11 (Crawled : 07:00) - globenewswire.com
SVNLF | $9.926 -0.24% -1.51% 0
|
Finance
|
| O: -0.25%
H: 2.63%
C: 0.0%
SVNLY | $4.9 340K
|
Finance and Insurance
|
| O: -0.25%
H: 2.28%
C: -0.51%
acquisition approval
Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicago
Published: 2022-09-22 (Crawled : 07:00) - biospace.com/
RLFTF | $1.43 2.14% 11.45% 0
|
n/a
|
| O: -20.21%
H: 40.17%
C: 33.19%
trial approval therapeutics initiated
Press Release: CHMP recommends approval of Beyfortus® (nirsevimab) for prevention of RSV disease in infants
Published: 2022-09-16 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 0
|
Health Technology
|
| O: 0.74%
H: 0.91%
C: -0.74%
SNY | News | $45.39 47K
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
beyfortus disease chmp approval
Kokam Strengthens Maritime Battery Storage Offering with 2021 DNV Approval
Published: 2022-07-04 (Crawled : 07:00) - prnewswire.com
SEDG 4 | $57.39 -3.93% -4.19% 3.3K
|
Producer Manufacturing
| Email alert
Add to watchlist
offering battery maritime approval
CHMP Recommends Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis
Published: 2022-06-27 (Crawled : 07:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 1.55%
H: 0.0%
C: 0.0%
rinvoq treatment active chmp approval
Ascensia Diabetes Care Announces European Approval of the Next-Generation Eversense E3 Continuous Glucose Monitoring System
Published: 2022-06-16 (Crawled : 07:00) - biospace.com/
SENS | $0.411 -1.2% 110K
|
Electronic Technology
|
| O: 1.01%
H: 0.0%
C: -4.64%
care system approval diabetes eversense
Alnylam Announces FDA Approval of AMVUTTRA™ (vutrisiran), an RNAi Therapeutic for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults
Published: 2022-06-14 (Crawled : 07:00) - biospace.com/
SNY | News | $45.39 47K
|
Health Technology
|
| O: -1.73%
H: 0.0%
C: 0.0%
ALNY | News | $145.16 -0.11% -0.19% 1
|
Health Technology
|
| O: 0.77%
H: 6.48%
C: 3.71%
treatment fda approval
Daqo New Energy's subsidiary Xinjiang Daqo Receives Approval from the CSRC for Its Planned Private Offering in China's A-Share Market
Published: 2022-06-09 (Crawled : 07:00) - prnewswire.com
DQ | $22.71 1.43% -0.09% 0
|
Process Industries
|
| O: -7.37%
H: 5.66%
C: 1.82%
offering approval market
CHMP Recommends European Commission Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Ulcerative Colitis
Published: 2022-05-23 (Crawled : 07:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
rinvoq treatment chmp approval ulcerative colitis
Cervical Dystonia Therapeutics Market Size to Grow by USD 154.77 Million | Market Research Insights Highlight expected Approval of Late-stage Pipeline Molecules as Key Driver | Technavio
Published: 2022-02-07 (Crawled : 07:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.55% 0
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
research approval therapeutics
CHMP Recommends Approval of Dupixent® (dupilumab) for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation
Published: 2022-01-31 (Crawled : 07:00) - prnewswire.com
SNY | News | $45.39 47K
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
REGN | $893.99 -0.8% -0.84% 0
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: -2.34%
dupixent approval chmp children
Graphic Packaging Holding Company Announces Receipt of All Required Regulatory Approvals for Pending Acquisition with AR Packaging
Published: 2021-10-13 (Crawled : 07:00) - prnewswire.com
GPK | $27.21 0.44% 0.0% 0
|
Process Industries
|
| O: 3.62%
H: 0.72%
C: -0.36%
acquisition approval
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
AGBA | News | $1.4 250.0% 35M
|
Finance
RWOD | $12.0 50.06% 3.9M
|
n/a
INDO | $4.9 20.1% 2.2M
|
Energy Minerals
NURO | $4.32 18.36% 66K
|
Health Technology
HUBC | $1.52 17.83% 4.7M
|
n/a
CARV 4 | $1.77 11.32% 8.5K
|
Finance
BROG | $1.23 10.81% 320K
|
Finance
PARA | $12.03 9.66% 5.8M
|
Information
ADAP | $0.98 9.08% 240K
|
Health Technology
POAI A | $1.25 8.69% 16K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.